Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Add-on vandetanib to docetaxel improves progression-free survival in NSCLC

Aug. 19, 2010

Crystal Biopharmaceutical describes new HDAC inhibitors

Aug. 19, 2010

Czech scientists disclose new cell division protein kinase inhibitors

Aug. 19, 2010

European Commission grants midostaurin orphan drug status in mastocytosis

Aug. 18, 2010

Abbott claims new PARP-1 inhibitors

Aug. 18, 2010

Avalon Pharma discloses new modulators of gene expression

Aug. 18, 2010

HemaQuest begins phase II HQK-1004 trial in EBV-related malignancies

Aug. 18, 2010

ValiRx to develop CRT's prostate cancer candidate VAL-201

Aug. 17, 2010

Merck KGaA discloses new MetAP 2 inhibitors

Aug. 17, 2010

Intellikine claims new PI3K and mTOR inhibitors

Aug. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...